Cancer BiologyBloodPeer-reviewed
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS
He Tian Chen, Pratik Joshi, Séverine Cathelin…·Kristin J. Hope
This study identifies MBD1-L, an aberrantly spliced transcript in MDS, which drives epigenetic changes leading to myeloerythroid defects, and shows ASO-based targeting can restore erythroid differentiation.
2 citationstop 4%